Portal vein infusion chemotherapy with gemcitabine after surgery for pancreatic cancer

Surgery Today

Volumn 43, Issue 1, 2013, Pages 33-39

  Kitami, Chi E ^a   Kurosaki, Isao ^a   Kawachi, Yasuyuki ^b   Nihei, Koei ^c   Tsuchiya, Yoshiaki ^d   Nomura, Tatsuya ^d   Minagawa, Masahiro ^a   Takano, Kabuto ^a   Hatakeyama, Katsuyoshi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b Nagaoka Chuo General Hospital   (Japan)

^c Tsuruoka Municipal Shonai Hospital   (Japan)

^d Niigata Hosp   (Japan)

Author keywords

Adjuvant chemotherapy; Gemcitabine; Liver metastasis; Pancreatic cancer; Portal vein infusion chemotherapy

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GEMCITABINE;

ABDOMINAL ABSCESS; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANOREXIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD TOXICITY; BLOODSTREAM INFECTION; BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; DELAYED STOMACH EMPTYING; DRUG DOSE REDUCTION; DRUG FEVER; DRUG INFUSION; DRUG INTERMITTENT THERAPY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN TISSUE; INTRAPERITONEAL ABSCESS; LEUKOPENIA; LIVER DYSFUNCTION; LIVER FUNCTION TEST; LIVER METASTASIS; MALE; NAUSEA; OPERATION DURATION; PANCREAS CANCER; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PATIENT MONITORING; PERCUTANEOUS DRAINAGE; PERITONEAL DISEASE; PILOT STUDY; PORTAL VEIN; POSTOPERATIVE CARE; PROSPECTIVE STUDY; SEPSIS; SIDE EFFECT; STOMACH FUNCTION DISORDER; THROMBOCYTOPENIA; VEIN SURGERY;

AGED; AGED, 80 AND OVER; CARCINOMA, DUCTAL; CHEMOTHERAPY, ADJUVANT; DEOXYCYTIDINE; FEASIBILITY STUDIES; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PANCREATECTOMY; PANCREATIC NEOPLASMS; PORTAL VEIN; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84871331262     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-012-0179-8     Document Type: Article

References (11)

1. Amikura K, Kobari M, Matsuno S. The time of occurrence of liver metastasis in carcinoma of the pancreas. Int J Pancreatol. 1995;17:139-246.
2. Ishikawa O, Ohigashi H, Sasaki Y, Furukawa H, Kabuto T, Kameyama M, et al. Liver perfusion chemotherapy via both the hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas. Am J Surg. 1994;168:361-4.
3. Ishikawa O, Ohhigashi H, Sasaki Y, Furukawa H, Imaoka S. Extended pancreatectomy and liver perfusion chemotherapy for resectable adenocarcinoma of the pancreas. Digestion. 1999;60(Suppl 1):135-8.
4. Kurosaki I, Kawachi Y, Nihei K, Tsuchiya Y, Aono T, Yokoyama N, et al. Liver perfusion chemotherapy with 5-fluorouracil followed by systemic gemcitabine administration for resected pancreatic cancer: preliminary results of a prospective phase 2 study. Pancreas. 2009;38:161-7.
5. Takahashi S, Ogata Y, Miyazaki H, Maeda D, Murai S, Yamataka K, et al. Aggressive surgery for pancreatic duct cell cancer: feasibility, validity, limitations. World J Surg. 1995;19:653-9.
6. Nakayama S, Takeda S, Kawase Y, Inoue S, Kaneko T, Nakao A. Clinical significance of dihydropyrimidine dehydrogenase in adjuvant 5-fluorouracil liver perfusion chemotherapy for pancreatic cancer. Ann Surg. 2004;240:840-4.
7. Ohigashi H, Ishikawa O, Eguchi H, Sasaki Y, Yamada T, Noura S, et al. Feasibility and efficacy of combination therapy with preoperative and postoperative chemoradiation, extended pancreatectomy, and postoperative liver perfusion chemotherapy for locally advanced cancers of the pancreatic head. Ann Surg Oncol. 2005;12:629-36.
8. Ohigashi H, Ishikawa O, Eguchi H, Takahashi H, Gotoh K, Yamada T, et al. Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer. Ann Surg. 2009;250:88-95.
9. Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, et al. Adjuvant chemotherapy with gemcitabine vs. observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA. 2007;297:267-77.
10. Ueno H, Kosuge T, Matsuyama Y, Yamamoto J, Nakao A, Egawa S, et al. A randomized phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. Br J Cancer. 2009;101:908-15.
11. Onoue M, Terada T, Okuda M, Fujimoto K, Doi R, Imamura M, et al. Surgical resection deteriorates gemcitabine-induced leucopenia in pancreatic cancer. Int J Clin Oncol. 2004;9:174-8.